Invention Grant
- Patent Title: Use of ultrarapid acting insulin
-
Application No.: US13357821Application Date: 2012-01-25
-
Publication No.: US09597374B2Publication Date: 2017-03-21
- Inventor: Anders Hasager Boss , Richard Petrucci , Campbell Howard , Alfred Mann
- Applicant: Anders Hasager Boss , Richard Petrucci , Campbell Howard , Alfred Mann
- Applicant Address: US CA Valencia
- Assignee: MannKind Corporation
- Current Assignee: MannKind Corporation
- Current Assignee Address: US CA Valencia
- Agency: K&L Gates LLP
- Agent Louis C. Cullman; Hal Gibson
- Main IPC: A61K38/28
- IPC: A61K38/28
Abstract:
Disclosed herein are improved methods of treating hyperglycemia with a combination of an ultrarapid acting insulin and insulin glargine comprising prandial administration of the ultrarapid insulin, and administration of a first dose of insulin glargine within 6 hours of waking for a day.
Public/Granted literature
- US20120122775A1 Use of Ultrarapid Acting Insulin Public/Granted day:2012-05-17
Information query
IPC分类:
